Passività Correnti Cambiamento Data
AstraZeneca USD 31.27B 286M 2026-09
Bayer EUR 29.4B 2.87B 2026-09
Essilor EUR 12.64B 490M 2026-06
Fresenius EUR 8.08B 986M 2026-09
Fresenius Medical Care EUR 7.91B 727.93M 2026-09
GlaxoSmithKline GBP 20.72B 814M 2026-09
GRIFOLS EUR 2.3B 59M 2026-09
Lonza CHF 3.57B 421M 2025-12
Merck EUR 8.96B 833M 2026-09
Novartis USD 32.52B 777M 2026-09
Philips EUR 7.91B 485M 2026-09
Roche Holding CHF 28.85B 846M 2026-06
Sanofi EUR 29.77B 2.16B 2026-09
Smith & Nephew USD 2.05B 510M 2026-06
Sonova Holding CHF 1.5B 303M 2025-06
UCB EUR 4.4B 470M 2025-12